113 related articles for article (PubMed ID: 38317321)
21. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
22. Sacubitril-Valsartan Ameliorates Heart Failure by Inhibiting Cardiac Remodeling Potentially via MAPK/ERK Signaling.
Zhang X; Yan C; Zheng M
Ann Clin Lab Sci; 2022 May; 52(3):391-938. PubMed ID: 35777797
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a rat model.
Alanazi WA; Alhamami HN; Alharbi M; Alhazzani K; Alanazi AS; Alsanea S; Ali N; Alasmari AF; Alanazi AZ; Alotaibi MR; Alswayyed M
Saudi Pharm J; 2022 Aug; 30(8):1159-1169. PubMed ID: 36164571
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of the Immunoproteasome LMP10 Subunit Attenuates Angiotensin II-Induced Cardiac Hypertrophic Remodeling via Autophagic Degradation of gp130 and IGF1R.
Yan W; Dong ZC; Wang JJ; Zhang YL; Wang HX; Zhang B; Li HH
Front Physiol; 2020; 11():625. PubMed ID: 32581853
[TBL] [Abstract][Full Text] [Related]
25. Myeloid differentiation 2 deficiency attenuates AngII-induced arterial vascular oxidative stress, inflammation, and remodeling.
Huang S; You S; Qian J; Dai C; Shen S; Wang J; Huang W; Liang G; Wu G
Aging (Albany NY); 2021 Jan; 13(3):4409-4427. PubMed ID: 33495414
[TBL] [Abstract][Full Text] [Related]
26. Rhein attenuates angiotensin II-induced cardiac remodeling by modulating AMPK-FGF23 signaling.
Lu W; Zhu H; Wu J; Liao S; Cheng G; Li X
J Transl Med; 2022 Jul; 20(1):305. PubMed ID: 35794561
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.
von Lueder TG; Wang BH; Kompa AR; Huang L; Webb R; Jordaan P; Atar D; Krum H
Circ Heart Fail; 2015 Jan; 8(1):71-8. PubMed ID: 25362207
[TBL] [Abstract][Full Text] [Related]
28. Asenapine maleate inhibits angiotensin II-induced proliferation and activation of cardiac fibroblasts via the ROS/TGFβ1/MAPK signaling pathway.
Wu HH; Meng TT; Chen JM; Meng FL; Wang SY; Liu RH; Chen JN; Ning B; Li Y; Su GH
Biochem Biophys Res Commun; 2021 May; 553():172-179. PubMed ID: 33773140
[TBL] [Abstract][Full Text] [Related]
29. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
[TBL] [Abstract][Full Text] [Related]
30. Liensinine improves AngII-induced vascular remodeling via MAPK/TGF-β1/Smad2/3 signaling.
Jia P; Chen D; Zhu Y; Wang M; Zeng J; Zhang L; Cai Q; Lian D; Zhao C; Xu Y; Chu J; Lin S; Peng J; Lin W
J Ethnopharmacol; 2023 Dec; 317():116768. PubMed ID: 37308031
[TBL] [Abstract][Full Text] [Related]
31. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
[TBL] [Abstract][Full Text] [Related]
32. Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension.
Olivares-Silva F; De Gregorio N; Espitia-Corredor J; Espinoza C; Vivar R; Silva D; Osorio JM; Lavandero S; Peiró C; Sánchez-Ferrer C; Díaz-Araya G
Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166241. PubMed ID: 34400298
[TBL] [Abstract][Full Text] [Related]
33. ALDH2 protects against alcoholic cardiomyopathy through a mechanism involving the p38 MAPK/CREB pathway and local renin-angiotensin system inhibition in cardiomyocytes.
Liu B; Zhang R; Wei S; Yuan Q; Xue M; Hao P; Xu F; Wang J; Chen Y
Int J Cardiol; 2018 Apr; 257():150-159. PubMed ID: 29506687
[TBL] [Abstract][Full Text] [Related]
34. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
36. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling.
Huang XR; Chung AC; Yang F; Yue W; Deng C; Lau CP; Tse HF; Lan HY
Hypertension; 2010 May; 55(5):1165-71. PubMed ID: 20231525
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1
Lin QY; Lang PP; Zhang YL; Yang XL; Xia YL; Bai J; Li HH
Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1301-H1311. PubMed ID: 31729904
[TBL] [Abstract][Full Text] [Related]
38. Cardiomyocyte-Specific Deletion of Orai1 Reveals Its Protective Role in Angiotensin-II-Induced Pathological Cardiac Remodeling.
Segin S; Berlin M; Richter C; Flockerzi RMV; Worley P; Freichel M; Londoño JEC
Cells; 2020 Apr; 9(5):. PubMed ID: 32354146
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent.
Qi G; Jia L; Li Y; Bian Y; Cheng J; Li H; Xiao C; Du J
Cardiovasc Toxicol; 2011 Jun; 11(2):157-67. PubMed ID: 21373977
[TBL] [Abstract][Full Text] [Related]
40. Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice.
Shu Q; Lai S; Wang XM; Zhang YL; Yang XL; Bi HL; Li HH
Biochem Biophys Res Commun; 2018 Oct; 505(1):317-324. PubMed ID: 30249396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
